Registration




   September 7 – 10, 2008, Belgrade

2ND EFIS/EJI BELGRADE SYMPOSIUM/POSTGRADUATE COURSE
Inflammation at the Interface of Innate and Acquired Immunity

SPEAKERS AND SESSION CHAIRS

 

Having in mind heterogeneity of the participants at this meeting and in order to facilitate informal contacts between students and faculty, we provide full addresses, picture and short biosketches of the invited speakers.  More information including references may be found on the Conference Website www.eji-efis.com as well as at the institutional or personal websites of the speakers.

page      1   2   3   4   5   6

 

                Professor Matthias von Herrath

Member/Professor, La Jolla Institute for Allergy & Immunology
9420 Athena Circle, La Jolla, CA 92037
E-mail: Matthias@liai.org

Dr. von Herrath is a full Member in the Division of Developmental Immunology. Dr. von Herrath's research focuses on strategies to prevent type 1 diabetes through the induction of regulatory T cells. Dr. von Herrath wrote his thesis in the field of Biochemistry and then received his M.D. in Medicine from the Freiburg Medical School in Freiburg, Germany. He went to The Scripps Research Institute for postdoctoral training. Dr. von Herrath is a member of the American Society of Clinical Investigation and in addition an Adjunct Professor of Pediatrics at the University of California, San Diego. He is the recipient of the 2006 Grotzky Award from the Juvenile Diabetes Foundation International and the 2007-2012 Scholar Award from the Juvenile Diabetes Foundation.

 

                Dr Stanislav Vukmanovic

Children's National Medical Center
Center for Cancer and Immunology Research (CCIR)
111 Michigan Avenue, NW
Washington, DC 20010-2970
E-mail: svukmano@cnmc.org

Dr. Vukmanovic obtained his MD and PhD from Belgrade University School of Medicine in 1984 and 1991, respectively. Subsequently, Dr. Vukmanovic joined the laboratory of Mike Bevan at University of Washington in Seattle as senior research associate, studying T lymphocyte development in the thymus. In 1993, Dr. Vukmanovic moved to New York to become an independent investigator at the NYU School of Medicine. Dr. Vukmanovic joined CRI in 2003. He is currently associate professor of pediatrics and immunology.. The focus of Dr. Vukmanovic's research is studying development and function of T lymphocytes with the goal to manipulate the immune system in diseases requiring either enhancement (cancer, infectious diseases) or dampening (autoimmune diseases, allergies, transplantation) of the immune functions.

 

                Professor Nikola L. Vujanovic

Research Associate Professor
Department of Pathology, University of Pittsburg School of Medicine
University of Pittsburgh Cancer Institute
Hillman Cancer Center, G. 17d, Research Pavilion
5117 Center Avenue, Pittsburgh, PA 15213-1863
Phone: 412-623-3211, Fax: 412-623-1119
E-mail: vujanovicnl@upmc.edu

Dr Vujanovic obtained his M.D. and PhD degree from the University of Belgrade and postdoctoral training at the University of Paris, France. His main research interests are related to the mechanisms of cytotoxicity mediated by immune effector cells and their role in anticancer host defense. His studies include the interactions between TNF family ligands of immune effector cells and TNF family receptors of cancer cells, leading to apoptosis or survival of cancer cells.

 

                Professor Hartmut Wekerle

Department of Neuroimmunology
Director and Head of the Basic Research Section
Max Planck Institute of Neurobiology
Department of Neuroimmunology
Am Klopferspitz 18, D-82152 Martinsried, Germany
Phone: +49 (0)89 - 8578-3551, Fax: +49 (0)89 - 8578-3790
E-mail: hwekerle@neuro.mpg.de

Hartmut Wekerle is Director at the Max Planck Institute of Neurobiology and Head of the Department of Neuroimmunology in Munich. He studied medicine at the University of Freiburg where he also gained his PhD. As a post-doctoral researcher, he worked at the Weizmann Institute of Science (Israel) and the Max Planck Institute for Immunobiology in Freiburg. Afterwards, he led the Research Group for Multiple Sclerosis at the Institute of Clinical Neurobiology at the University Hospital of the University of Wurzburg. In 1988, he was appointed Director at the Max Planck Institute for Neurobiology. Professor Wekerle’s scientific research is focused on the underlying reasons and mechanisms of diseases which arise due to a conflict between the immune system and the nervous system, his main focus being on multiple sclerosis.

 

                Professor Georg Wick

Head, Division for Experimental Pathology and Immunology
Laboratory for Autoimmunity Biocenter
Innsbruck Medical University
Peter-Mayr-Straße 4a, 6020 Innsbruck
Phone: 0043 (0)512 -9003-70960/FAX: 0043 (0)512 -9003-73960
E-mail: georg.wick@i-med.ac.at

 

Georg Wick is Professor Emeritus in the Laboratory of Immunopathology at the Medical University of Innsbruck. He is also the former President of the Austrian Science Fund. His scientific fields of interest are centered on the topics of autoimmunity and autoimmune diseases, immunology of aging with special emphasis on immune-inflammatory processes in atherosclerosis, and the interaction of the immune and endocrine systems. In 1975, he was appointed Professor and Chairman for Pathophysiology and Immunology at the University of Innsbruck Medical School, where, from 1991 – 2003, he also was Director of the newly founded Institute for Biomedical Aging Research of the Austrian Academy of Sciences.

 

page      1   2   3   4   5   6


 
Supported by Medical Faculty University of Kragujevac